Lilly/PCS consent order should require closed formulary P&T committee -- NACDS/Citizen Action letter.
Executive Summary
LILLY/PCS CONSENT ORDER SHOULD REQUIRE P&T COMMITTEE FOR CLOSED FORMULARY, NACDS and Citizen Action jointly requested in a June 23 letter to Federal Trade Commission Chairman Robert Pitofsky. Representatives of the 3 mil. member consumer group Citizen Action and the National Association of Chain Drug Stores met with Pitofsky and FTC Commissioner Janet Steiger the week of June 12 to urge FTC's reconsideration of the acquisition of the pharmacy benefit management firm PCS by Lilly from McKesson.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth